journal article·2022

Boron- and phosphorus-containing molecular/nano platforms: exploiting pathological redox imbalance to fight cancer

Anna Wolfram, Pablo Fuentes-Soriano, Christel Herold-Mende, Carlos Romero-Nieto

Nanoscale· Volume 14· Issue 47
Publisher page

Abstract

Cancer is currently the second leading cause of death globally. Despite multidisciplinary efforts, therapies to fight various types of cancer still remain inefficient. Reducing high recurrence rates and mortality is thus a major challenge to tackle. In this context, redox imbalance is an undervalued characteristic of cancer. However, it may be targeted by boron- and phosphorus-containing materials to selectively or systemically fight cancer. In particular, boron and phosphorus derivatives are attractive building blocks for rational drug discovery due to their unique and wide regioselective chemistry, high degree of tuneability and chemical stability. Thus, they can be meticulously employed to access tunable molecular platforms to selectively exploit the redox imbalance of cancer cells towards necrosis/apoptosis. This field of research holds a remarkable potential; nevertheless, it is still in its infancy. In this mini-review, we underline recent advances in the development of boron- or phosphorus-derivatives as molecular/nano platforms for rational anticancer drug design. Our goal is to provide comprehensive information on different methodologies that bear an outstanding potential to further develop this very promising field of research.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Boron Compounds in Chemistry · Metal-Organic Frameworks: Synthesis and Applications · MXene and MAX Phase Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Faculty of Pharmacy, University of Castilla-La Mancha Calle Almansa 14 – Edif. Bioincubadora, 02008, Albacete, Spain

Division of Neurosurgical Research, Department of Neurosurgery, Ruprecht-Karls-Universität Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany

Organisch-Chemisches Institut, Ruprecht-Karls-Universität Heidelberg, Im Neuenheimer Feld 270, 69120 Heidelberg, Germany

Funding

Junta de Comunidades de Castilla-La Mancha · Ministerio de Ciencia e Innovación · Deutsche Forschungsgemeinschaft · Agencia Estatal de Investigación

References (100+)

Show source-provided references
1. Sung · CA Cancer J. Clin. · 2021 · 71 · 20910.3322/caac.21660 ↗
2. A.Bauer , R.-D.Hofheinz and J.Utikal , Ethical Challenges in Cancer Diagnosis and Therapy , 202110.1007/978-3-030-63749-1 ↗
3. Maeda · Clin. Transl. Med. · 2018 · 7 · 1110.1186/s40169-018-0185-6 ↗
4. Mansoori · Adv. Pharm. Bull. · 2017 · 7 · 33910.15171/apb.2017.041 ↗
5. Gius · Antioxid. Redox Signal. · 2006 · 8 · 124910.1089/ars.2006.8.1249 ↗
6. Bakalova · Clin. Cancer Res. · 2013 · 19 · 250310.1158/1078-0432.CCR-12-3726 ↗
7. Jorgenson · Cancer Res. · 2013 · 73 · 611810.1158/0008-5472.CAN-13-1117 ↗
8. Di Meo · Oxid. Med. Cell. Longevity · 2016 · 124504910.1155/2016/1245049 ↗
9. Visconti · Curr. Opin. Drug Discovery Dev. · 2009 · 12 · 240
10. Reuter · Free Radicals Biol. Med. · 2010 · 49 · 160310.1016/j.freeradbiomed.2010.09.006 ↗
11. Tafani · Oxid. Med. Cell. Longevity · 2016 · 2016 · 390714710.1155/2016/3907147 ↗
12. Gandin · Molecules · 2015 · 20 · 1273210.3390/molecules200712732 ↗
13. di Ilio · Cancer Lett. · 1985 · 29 · 3710.1016/0304-3835(85)90120-X ↗
14. Dagnell · Free Radicals Biol. Med. · 2018 · 115 · 48410.1016/j.freeradbiomed.2017.12.029 ↗
15. Yan · Cancer Res. · 2019 · 79 · 12510.1158/0008-5472.CAN-18-1938 ↗
16. Patwardhan · Transl. Oncol. · 2022 · 17 · 10134110.1016/j.tranon.2022.101341 ↗
17. Khramtsov · Antioxid. Redox Signal. · 2014 · 21 · 72310.1089/ars.2014.5864 ↗
18. Kennedy · Biomolecules · 2020 · 10 · 110.3390/biom10101429 ↗
19. Zou · Chem. Soc. Rev. · 2015 · 44 · 878610.1039/C5CS00132C ↗
20. Andricopulo · Curr. Top. Med. Chem. · 2009 · 9 · 77110.2174/156802609789207127 ↗
21. Baker · Future Med. Chem. · 2009 · 1 · 127510.4155/fmc.09.71 ↗
22. E.Hey-Hawkins and C. V.Teixidor , Boron-Based Compounds: Potential and Emerging Applications in Medicine , Wiley , 201810.1002/9781119275602 ↗
23. Ali · Molecules · 2020 · 25 · 82810.3390/molecules25040828 ↗
24. Song · Acta Pharm. Sin. B · 2021 · 11 · 303510.1016/j.apsb.2021.01.010 ↗
25. Saxon · ChemBioChem · 2022 · 23 · e20210036610.1002/cbic.202100366 ↗
26. Y.Zhu , J.Cai , N. S.Hosmane and Y.Zhang , in Fundamentals and Applications of Boron Chemistry , ed. Y. Zhu , Elsevier , 2022 , vol. 2 , pp. 1–57
27. Romero-Nieto · Synlett · 2016 · 27 · 229310.1055/s-0035-1562506 ↗
28. Fernandez-Garcia · Life · 2017 · 7 · 3110.3390/life7030031 ↗
29. Hindenberg · Chemistry · 2017 · 23 · 1391910.1002/chem.201701649 ↗
30. Papathanasiou · Pure Appl. Chem. · 2019 · 91 · 42110.1515/pac-2018-1012 ↗
31. Regulska · Mater. Today Chem. · 2021 · 22 · 10060410.1016/j.mtchem.2021.100604 ↗
32. Diaz · Nat. Chem. · 2017 · 9 · 73110.1038/nchem.2814 ↗
33. Fyfe · Chem · 2017 · 3 · 3110.1016/j.chempr.2017.05.008 ↗
34. Liu · Adv. Sci. · 2021 · 8 · 200303310.1002/advs.202003033 ↗
35. Rodriguez · ChemMedChem · 2019 · 14 · 19010.1002/cmdc.201800693 ↗
36. Ruiz · Nanoscale Adv. · 2021 · 3 · 402910.1039/D1NA00203A ↗
37. Tang · Matter · 2020 · 2 · 29710.1016/j.matt.2019.12.007 ↗
38. Xing · Adv. Healthcare Mater. · 2018 · 7 · 170151010.1002/adhm.201701510 ↗
39. Lesnikowski · Expert Opin. Drug Discovery · 2016 · 11 · 56910.1080/17460441.2016.1174687 ↗
40. Hagen · J. Med. Chem. · 2012 · 55 · 92410.1021/jm2014937 ↗
41. Chen · J. Med. Chem. · 2014 · 57 · 449810.1021/jm401349g ↗
42. Takagi · Chem. – Asian J. · 2017 · 12 · 265610.1002/asia.201701004 ↗
43. Fan · ACS Pharmacol. Transl. Sci. · 2021 · 4 · 68710.1021/acsptsci.0c00092 ↗
44. Viry · ChemMedChem · 2008 · 3 · 166710.1002/cmdc.200800210 ↗
45. Jortzik · Biochim. Biophys. Acta · 2014 · 1844 · 141510.1016/j.bbapap.2014.01.006 ↗
46. Roesch · Chem. Commun. · 2020 · 56 · 1459310.1039/D0CC05761D ↗
47. Fermi · Chemistry · 2022 · 28 · e20210453510.1002/chem.202104535 ↗
48. Gao · Front. Pharmacol. · 2019 · 10 · 27010.3389/fphar.2019.00270 ↗
49. Liu · Chem. Sci. · 2020 · 11 · 1143510.1039/D0SC03349A ↗
50. Peng · Colloids Surf., B · 2021 · 198 · 11146710.1016/j.colsurfb.2020.111467 ↗
51. Zhang · Biomater. Sci. · 2021 · 9 · 530210.1039/D1BM00106J ↗
52. Khaliq · Biol. Trace Elem. Res. · 2018 · 186 · 3110.1007/s12011-018-1284-3 ↗
53. Zhang · Chem. Soc. Rev. · 2017 · 46 · 674610.1039/C7CS00261K ↗
54. Charzewski · Front. Mol. Biosci. · 2021 · 8 · 63318110.3389/fmolb.2021.633181 ↗
55. Barth · Radiat. Oncol. · 2012 · 7 · 14610.1186/1748-717X-7-146 ↗
56. Barth · Cancer Commun. · 2018 · 38 · 3510.1186/s40880-018-0299-7 ↗
57. Gough · Cell Death Dis. · 2011 · 2 · e21310.1038/cddis.2011.96 ↗
58. Glasauer · Biochem. Pharmacol. · 2014 · 92 · 9010.1016/j.bcp.2014.07.017 ↗
59. Lennicke · Cell Commun. Signaling · 2015 · 13 · 3910.1186/s12964-015-0118-6 ↗
60. Halliwell · FEBS Lett. · 2000 · 486 · 1010.1016/S0014-5793(00)02197-9 ↗
61. Wu · Chem. Sci. · 2019 · 10 · 706810.1039/C9SC01070J ↗
62. Luqmani · Med. Princ. Pract. · 2005 · 14 · 3510.1159/000086183 ↗
63. Zahreddine · Front. Pharmacol. · 2013 · 4 · 2810.3389/fphar.2013.00028 ↗
64. M. M.Safhi , S. M.Sivakumar , A.Jabeen , F.Zakir , F.Islam , T.Anwer , U. S.Bagul , M. E.Elmobark , G.Khan , R.Siddiqui , A.Hussien and M. F.Alam , in Multifunctional Systems for Combined Delivery, Biosensing and Diagnostics , ed. A. M. Grumezescu , Elsevier , 2017 , pp. 159–169 , 10.1016/b978-0-323-52725-5.00008-310.1016/b978-0-323-52725-5.00008-3 ↗
65. Chen · J. Med. Chem. · 2018 · 61 · 913210.1021/acs.jmedchem.8b00559 ↗
66. Chen · Chemistry · 2014 · 20 · 741010.1002/chem.201400090 ↗
67. Chen · Front. Pharmacol. · 2018 · 9 · 145310.3389/fphar.2018.01453 ↗
68. C. S.Chu and S. C.Rubin , in Clinical Gynecologic Oncology , ed. P. J. Di Saia , W. T. Creasman , R. S. Mannel , D. S. McMeekin and D. G. Mutch , Elsevier , Philadelphia , 2018 , pp. 449–469 , 10.1016/B978-0-323-40067-1.00017-610.1016/B978-0-323-40067-1.00017-6 ↗
69. Hall · Blood Rev. · 1992 · 6 · 16310.1016/0268-960X(92)90028-O ↗
70. S. M.Konstantinov and M. R.Berger , in Encyclopedia of Molecular Pharmacology , ed. S. Offermanns and W. Rosenthal , Springer Berlin Heidelberg , Berlin, Heidelberg , 2008 , ch. 178, pp. 53–5710.1007/978-3-540-38918-7_178 ↗
71. Lajous · Trends Pharmacol. Sci. · 2019 · 40 · 34210.1016/j.tips.2019.03.003 ↗
72. Schikora · Bioorg. Med. Chem. Lett. · 2015 · 25 · 344710.1016/j.bmcl.2015.07.013 ↗
73. Reshetnikov · Dalton Trans. · 2018 · 47 · 667910.1039/C8DT01458B ↗
74. Xu · J. Organomet. Chem. · 2022 · 964 · 12230510.1016/j.jorganchem.2022.122305 ↗
75. Trachootham · Nat. Rev. Drug Discovery · 2009 · 8 · 57910.1038/nrd2803 ↗
76. Petronek · Redox Biol. · 2021 · 42 · 10186410.1016/j.redox.2021.101864 ↗
77. Aggarwal · Biomolecules · 2019 · 9 · 73510.3390/biom9110735 ↗
78. Saravanakumar · Adv. Sci. · 2017 · 4 · 160012410.1002/advs.201600124 ↗
79. Luo · J. Controlled Release · 2018 · 274 · 5610.1016/j.jconrel.2018.01.034 ↗
80. Circu · Free Radical Biol. Med. · 2010 · 48 · 74910.1016/j.freeradbiomed.2009.12.022 ↗
81. Alkazemi · Sci. Rep. · 2021 · 11 · 303410.1038/s41598-021-82579-5 ↗
82. Lipinski · Oxid. Med. Cell. Longevity · 2011 · 2011 · 80969610.1155/2011/809696 ↗
83. Daum · Bioconjugate Chem. · 2019 · 30 · 107710.1021/acs.bioconjchem.9b00019 ↗
84. Özkan · Eur. J. Inorg. Chem. · 2021 · 2021 · 509610.1002/ejic.202100829 ↗
85. Wang · Angew. Chem., Int. Ed. · 2014 · 53 · 1344410.1002/anie.201407234 ↗
86. Hoang · Angew. Chem., Int. Ed. · 2017 · 56 · 261910.1002/anie.201611446 ↗
87. Liao · ACS Med. Chem. Lett. · 2018 · 9 · 63510.1021/acsmedchemlett.8b00057 ↗
88. Engel · J. Neurochem. · 2019 · 149 · 53510.1111/jnc.14655 ↗
89. Jiang · ACS Med. Chem. Lett. · 2012 · 3 · 39210.1021/ml3000287 ↗
90. Zhong · BMC Cancer · 2015 · 15 · 62510.1186/s12885-015-1621-2 ↗
91. Zhang · Breast Cancer Res. Treat. · 2015 · 152 · 28310.1007/s10549-015-3461-9 ↗
92. Anju · Mater. Sci. Eng., C · 2019 · 97 · 97810.1016/j.msec.2018.12.146 ↗
93. Chen · Adv. Mater. · 2017 · 29 · 160386410.1002/adma.201603864 ↗
94. Romero-Nieto · Angew. Chem., Int. Ed. · 2015 · 54 · 1587210.1002/anie.201507960 ↗
95. Zhao · J. Nanobiotechnol. · 2021 · 19 · 18110.1186/s12951-021-00932-2 ↗
96. Sultana · Mater. Adv. · 2022 · 3 · 555710.1039/D1MA01101D ↗
97. Yu · Med. Drug Discovery · 2020 · 8 · 10006310.1016/j.medidd.2020.100063 ↗
98. Park · Int. J. Oncol. · 2014 · 45 · 169110.3892/ijo.2014.2579 ↗
99. Onodera · Chem. Pharm. Bull. · 2019 · 67 · 18610.1248/cpb.c18-00767 ↗
100. Yue · Front. Chem. · 2020 · 8 · 54310.3389/fchem.2020.00543 ↗